Tag : Biopharmaceutical

Biology

Study Finds Pandemic Likely to Negatively Impact Biopharmaceutical Sector

Newsemia
BOSTON (PRWEB) May 21, 2020 Threats to intellectual property, political pressure to lower prices, disruption of clinical trials will cause long-term harm Contrary to conventional...
Latest News

Oxford University vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques

Newsemia
As the world continues to grapple with the coronavirus pandemic, many scientists, institutions, and pharmaceutical companies are working hard to develop an effective vaccine. Source...
Latest News

Avantor launches new Protein A Chromatography Resin – PROchievA – that provides supply chain flexibility and improves downstream purification performance for monoclonal antibodies (mAbs) production

Newsemia
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced...
Latest News

Beijing Tide Pharmaceutical and Insilico Medicine announce cancer drug discovery collaboration

Newsemia
Beijing Tide Pharmaceutical Co., Ltd., a subsidiary of Sino Biopharmaceutical Limited, and Insilico Medicine, an artificial intelligence company developing end-to-end drug discovery pipelines, announced today...
Latest News

Sartorius launches BioPAT Spectro for use with ambr systems and BIOSTAT STR

Newsemia
Sartorius, a leading international partner of the biopharmaceutical industry today introduced BioPAT Spectro, a Quality by Design tool for use with its ambr automated micro...
Latest News

Blue Water Vaccines enters into agreement to develop Streptococcus pneumoniae vaccine with St. Jude

Newsemia
Blue Water Vaccines Inc., a biopharmaceutical company focused on creating transformative vaccines solving global health challenges, has entered into an exclusive worldwide license agreement for...
Latest News

Samenvatting: Abzena organiseert op 19 februari 2020 het tweede Biopharmaceutical Discovery and Development Symposium in Cambridge, Verenigd Koninkrijk

Newsemia
CAMBRIDGE, Engeland–(BUSINESS WIRE)–Abzena, de wereldwijde biologische target-to-GMP Partner Research Organization, maakt vandaag bekend dat het de tweede Biopharmaceutical Discovery and Development Symposium organiseert op de...
Latest News

Entos Pharmaceuticals signs new collaboration agreement with biopharmaceutical company

Newsemia
Entos Pharmaceuticals Inc. (“Entos” or the “Company”), a healthcare biotechnology company focused on the development of next-generation nucleic acid-based therapies using their Fusogenix drug delivery...
Neurology

Alzheimer's Association awards $3 million grant to support Longeveron's innovative clinical trial

Newsemia
The Alzheimer’s Association has awarded Longeveron LLC, a Miami-based biopharmaceutical company that develops cellular therapies for aging-related diseases, a $3 million grant to be applied...
Latest News

World Commercial Biotechnology Separation Systems Market Report 2019 – Surging Biopharmaceutical Market Spurs Demand for Bioseparation Systems – ResearchAndMarkets.com

Newsemia
DUBLIN–(BUSINESS WIRE)–The "Commercial Biotechnology Separation Systems: Global Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering. This report provides separate comprehensive analytics...
Latest News

NCCN and AstraZeneca collaborate to improve care processes for lung cancer patients

Newsemia
The National Comprehensive Cancer Network Oncology Research Program and AstraZeneca, a global, science-led biopharmaceutical company, are collaborating to seek proposals for improving care processes for...
Latest News

PPS and BioAnalytix announce merger to create global analytic service partner for biopharmaceuticals

Newsemia
Protagen Protein Services GmbH, a full-service contract research organization in protein analytics and BioAnalytix Inc., a Cambridge-based specialized provider of advanced analytics in biopharmaceutical development...
Latest News

NIAID awards $22 million grant to develop antibody-based therapies against lethal viruses

Newsemia
The National Institute of Allergy and Infectious Diseases has awarded an international consortium led by Albert Einstein College of Medicine, part of Montefiore, a five-year,...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy